Profile data is unavailable for this security.
About the company
Hemostemix Inc. is an autologous stem cell therapy platform company. The Company has developed, patented, and is scaling and selling autologous (patient’s own) blood-based stem cell therapies that include angiogenic cell precursors (ACP-01), later neural cell precursors (NCP-01), and cardiomyocyte cell precursors (CCP-01). It holds 91 patents on the derivation of three stem cell lineages from the patient’s blood, including ACP-01, CCP-01 and NCP-01. ACP-01 is a clinically relevant and statistically significant treatment for peripheral arterial disease, chronic limb-threatening ischemia, non-ischemic dilated cardiomyopathy, ischemic cardiomyopathy, congestive heart failure, and angina. It has completed a Phase II clinical trial for chronic limb-threatening ischemia. It has two wholly owned subsidiaries, Kwalata Trading Limited and PreCerv Inc. PreCerv Inc. holds a global field of use license to ACP-01 & NCP-01 for the treatment of conditions of the central and peripheral nervous system.
- Revenue in CAD (TTM)0.00
- Net income in CAD-3.40m
- Incorporated2014
- Employees--
- LocationHemostemix Inc707 7th Ave. SW, Suite 1150CALGARY T2P 3H6CanadaCAN
- Phone+1 (905) 580-4170
- Fax+1 (403) 818-7672
- Websitehttps://hemostemix.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| COSCIENS Biopharma Inc | 12.27m | -20.20m | 8.66m | 21.00 | -- | 1.26 | -- | 0.7058 | -6.41 | -6.41 | 3.88 | 2.16 | 0.2678 | 1.96 | 5.18 | -- | -44.08 | -24.51 | -53.74 | -27.91 | 45.14 | 62.83 | -164.63 | -175.84 | 3.03 | -- | 0.2994 | -- | 34.22 | 78.30 | -339.28 | -- | -- | -- |
| Marvel Biosciences Corp | 0.00 | -2.28m | 8.99m | -- | -- | -- | -- | -- | -0.045 | -0.045 | 0.00 | -0.0635 | 0.00 | -- | -- | -- | -499.17 | -239.13 | -- | -- | -- | -- | -- | -- | -- | -4.89 | -- | -- | -- | -- | -34.02 | -- | -- | -- |
| Medicure Inc | 26.21m | -3.43m | 11.90m | 23.00 | -- | 0.6874 | -- | 0.454 | -0.3286 | -0.3286 | 2.51 | 1.66 | 0.9492 | 3.90 | 5.93 | 1,139,435.00 | -12.42 | -5.22 | -17.87 | -7.48 | 47.67 | 60.98 | -13.08 | -8.17 | 1.00 | -- | 0.0546 | -- | 0.9818 | 1.66 | -12.69 | -- | -44.35 | -- |
| Innovotech Inc | 4.46m | 383.40k | 13.61m | 16.00 | 26.18 | 4.73 | 27.79 | 3.05 | 0.0096 | 0.0096 | 0.0923 | 0.0529 | 1.85 | 19.32 | 7.96 | -- | 15.26 | 6.12 | 18.38 | 7.33 | 47.12 | 65.29 | 8.27 | 5.49 | 4.45 | -- | 0.00 | -- | 85.56 | 17.35 | 242.62 | -- | 141.95 | -- |
| Neurothera Labs Inc | 0.00 | -209.09k | 15.71m | -- | -- | 3.76 | -- | -- | -0.0116 | -0.0116 | 0.00 | 0.0493 | 0.00 | -- | -- | -- | -19.28 | -- | -21.28 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -143.95 | -- | -- | -- |
| Sirona Biochem Corp | -16.37k | -2.67m | 15.82m | -- | -- | -- | -- | -- | -0.0105 | -0.0105 | -0.00006 | -0.0134 | -0.0171 | -- | 1.61 | -- | -278.90 | -173.09 | -- | -383.49 | -- | -- | -- | -1,405.28 | -- | -5.73 | -- | -- | -94.82 | -51.37 | 28.52 | -- | -- | -- |
| Numinus Wellness Inc | 5.33m | -10.67m | 16.32m | 35.00 | -- | -- | -- | 3.06 | -0.0366 | -0.0481 | 0.0175 | -0.0049 | 0.5827 | -- | 3.41 | -- | -116.67 | -77.90 | -231.32 | -88.05 | 44.96 | 31.24 | -200.23 | -325.94 | -- | -- | 3.02 | -- | -82.02 | -- | 51.75 | -- | -- | -- |
| Hemostemix Inc | 0.00 | -3.40m | 16.60m | -- | -- | -- | -- | -- | -0.03 | -0.03 | 0.00 | -0.0188 | 0.00 | -- | -- | -- | -453.77 | -579.31 | -- | -- | -- | -- | -- | -- | -- | -6.01 | -- | -- | -- | -- | -4.57 | -- | -- | -- |
| Avicanna Inc | 25.50m | -1.88m | 21.23m | 38.00 | -- | 6.82 | -- | 0.8326 | -0.0165 | -0.0165 | 0.2262 | 0.0264 | 1.22 | 2.89 | 10.84 | -- | -9.02 | -61.54 | -51.98 | -226.72 | 51.95 | 49.33 | -7.37 | -150.05 | 0.3804 | -- | 0.00 | -- | 51.62 | 172.88 | 58.62 | -- | -44.27 | -- |
